Nihon Kohden Corporation operates within the Electromedical equipment sector. In addition to historical fundamental analyses, the complete report available to purchase compares Nihon Kohden with three other medical equipment manufacturers in Asia: Fukuda Denshi Co., Ltd. (2017 sales of 121.75 billion Japanese Yen [US$1.12 billion] of which 39% was Treatment Equipment), Japan Lifeline Co., Ltd. (37.18 billion Japanese Yen [US$342.07 million] of which 47% was EP/Application), and Microport Scientific Corp which is based in China (2.99 billion Chinese Renmimbi [US$473.57 million] of which 51% was Orthopedics Devices).

Sales Analysis. During the year ended March of 2017, sales at Nihon Kohden were ¥166.29 billion (US$1.53 billion). This is a very small increase of 0.5% versus 2016, when the company's sales were ¥165.52 billion. This was the fifth consecutive year of sales increases at Nihon Kohden (and since 2012, sales have increased a total of 38%). Sales of Others saw an increase that was more than double the company's growth rate: sales were up 4.7% in 2017, from ¥40.87 billion to ¥42.78 billion. Nihon Kohden also saw significant increases in sales in Biological Information Monitors (up 2.4% to ¥56.12 billion) . Not all segments of Nihon Kohden experienced an increase in sales in 2017: sales of Biological Measuring Equipment fell 4.0% to ¥37.66 billion. Nihon Kohden also experienced decreases in sales in Treatment Equipment (down 2.9% to ¥29.73 billion) .